Q97969513

Summary

Q97969513 is a motion^[1].

Key Facts

• Q97969513 authored Ulla-Britt Hagström^[2].
• Q97969513 authored Ulla-Britt Hagström^[3].
• Q97969513's instance of is recorded as motion^[4].
• Q97969513's part of the series is recorded as motions of the 1998-1999 legislative session of the Riksdag^[5].
• Q97969513's language of work or name is recorded as Swedish^[6].
• Q97969513's publication date is recorded as +1998-10-28T00:00:00Z^[7].
• Q97969513's main subject is recorded as medication^[8].
• Q97969513's work available at URL is recorded as http://data.riksdagen.se/dokument/GM02So234^[9].
• Q97969513's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GM02So234^[10].
• Q97969513's applies to jurisdiction is recorded as Sweden^[11].
• Q97969513's legal citation of this text is recorded as Mot. 1998/99:So234^[12].
• Q97969513's title is recorded as Könsspecifik märkning av läkemedel^[13].
• Q97969513's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97969513's copyright status is recorded as public domain^[15].
• Q97969513's legislative committee is recorded as Committee on Health and Welfare^[16].
• Q97969513's Swedish Riksdag document ID is recorded as GM02So234^[17].

Body

Works and Contributions

Authored works include Ulla-Britt Hagström^[2], a politician^[18], b. 1945^[19], of Sweden^[20].